Register to receive a free Interventional Cardiology Devices Market Report Suite for Europe 2018-2024 synopsis and brochure
The European interventional cardiology market is currently valued at nearly $1.4 billion. This is a mature market that has been in decline for many years as a result of market-wide factors, such as lack of innovation, consistent price erosion and increased competition. In recent years, the interventional cardiology market has been experiencing a period of consolidation, whereby large competitors are entering new market segments organically or through strategic mergers and acquisitions. This has resulted in tremendous downward pricing pressure, as consolidated companies have more power to bundle various devices at a discount in order to win tenders and contract offers with hospitals and labs.
Recent Mergers and Acquisition in Interventional Cardiology
A closer analysis of recent market transactions reveals that deals are, on average, becoming increasingly large in size. This trend is not unique to interventional cardiology markets and is prevalent in other mature medical device markets as well. Market segments that are smaller in size — like vascular closure devices, optical coherenace tomography (OCT) catheters and fractional flow reserve (FFR) guidewires — will be affected the most by recent market transactions. Recent cardiology mergers include:
VCD Market Has the Greatest Downside
The vascular closure devices (VCD) market segment is expected to be amongst the most negatively affected in the market, as the anticipated price erosion will outpace growth in sales volume. In addition…
This article was originally published on DAIC, to read more please visit https://www.dicardiology.com/article/recent-acquisitions-eroding-prices-billion-dollar-european-interventional-cardiology-market
For Further Market Information
More can be found in a series of reports published by iData Research entitled the Europe Market Report Suite for Interventional Cardiology Devices 2018.